The Melbourne Atopy Cohort Study (MACS): A Randomised controlled trial of a partially hydrolysed whey and a soy formula for the prevention of allergic disease.

Not Applicable

Active, not recruiting

• Conditions: Allergic manifestationsEczemaAsthmaAllergic rhinitisAtopy; Allergic manifestations; Eczema; Asthma; Allergic rhinitis; Atopy; Inflammatory and Immune System - Allergies; Diet and Nutrition - Other diet and nutrition disorders

• Registration Number: ACTRN12609000734268
• Lead Sponsor: estec Ltd,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-08-25
• Last Update Posted: 5 August 2024

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 620

Inclusion Criteria

Family history of allergic disease (asthma, eczema, allergic rhinitis or severe food allergy)

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Allergic manifestations (eczema, food reactions, urticaria) assessed by telephone interview of parent[ up to 2 years age. Telephone interviews were undertaken 18 times during the first two years of life (every 4 weeks until 64 weeks, then at 78 and 104 weeks)]